Related Experiment Video
Updated: Mar 28, 2026

09:53
In Vivo Nanovector Delivery of a Heart-specific MicroRNA-sponge
Published on: June 15, 2018
8.0K
A Multi-RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs.
Young Hoon Roh1,2,3, Jason Z Deng1,2, Erik C Dreaden1,2
1Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
Angewandte Chemie (International Ed. in English)
|December 24, 2015
Summary
Researchers developed novel nanostructures for RNA interference therapy. These Multi-RNAi-MSs efficiently package multiple small interfering RNA (siRNA) molecules for enhanced treatment of diseases.
Area of Science:
- Biotechnology
- Nanotechnology
- Molecular Biology
Background:
- Effective RNA interference (RNAi) therapy requires precise packaging of small interfering RNA (siRNA) molecules into nanostructures.
- Current delivery strategies face challenges in achieving controlled stoichiometry and simultaneous packaging of multiple siRNA components.
Purpose of the Study:
- To develop a novel RNA nanotechnology-based approach for creating composite microstructures (Multi-RNAi-MSs) capable of packaging multiple siRNA molecules at defined ratios.
- To engineer Multi-RNAi-MSs for optimized physicochemical properties for enhanced delivery and therapeutic efficacy.
Main Methods:
- Utilized rolling circle transcription to synthesize polymerized siRNA molecules.
- Self-assembled and densely packaged multiple siRNA components into sponge-like porous microstructures (Multi-RNAi-MSs).
- Employed polyelectrolyte condensation to convert Multi-RNAi-MSs into nanosized complexes with tailored properties.
Main Results:
- Successfully produced Multi-RNAi-MSs containing multiple polymeric siRNA molecules with precisely controlled stoichiometry.
- Demonstrated the ability to manipulate physicochemical properties (size, shape, surface charge) of the nanostructures for improved delivery.
- Maintained the multifunctional properties of the encapsulated siRNAs for combined therapeutic effects.
Conclusions:
- The developed Multi-RNAi-MS system offers a powerful strategy for simultaneous delivery of multiple siRNAs.
- These nanostructures hold significant potential for advancing RNAi-mediated therapies for cancer, genetic disorders, and viral infections.
Related Concept Videos
RNA Interference
28.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
28.6K
RNA Interference
7.8K
7.8K
Experimental RNAi
8.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
8.3K
siRNA - Small Interfering RNAs
19.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
19.0K
Small interfering RNAs (siRNA)
5.2K
5.2K
MicroRNAs
24.6K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.6K

